The National Stock Exchange of India (NSE) is preparing for its IPO, boasting over 1 lakh shareholders, surpassing many ...

The gold lender reported profit after tax of Rs 1,500 crore in Q4 FY25, up 43 per cent year-on-year (YoY) and in line with ...

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Xarelto Tablets, 2.5 mg, 10 mg, ...

Infosys has reportedly told its employees that the performance bonuses for the Q4 2025 will be lower than expected.

On a consolidated basis, Nilkamal's net profit gained 58.35% to Rs 34.22 crore in Q4 FY25 as against Rs 21.61 crore in Q3 FY25. Revenue from operations rose 4.65% to Rs 894.01 crore in Q4 FY25 over Q3 ...